衰弱特征量表简版:适用于临床实践的衰弱评估工具
基于Toledo健康老龄化研究1634名参与者的前瞻性队列数据,开发了5条目(FTS5)和3条目(FTS3)的衰弱特征量表简版。FTS5对不良健康事件的预测能力与12条目原版相似,且优于Fried表型,尤其能区分衰弱前期个体的风险分层;FTS3存在较高假阴性。
要点
- FTS5(0-50分) cutoff >25,衰弱患病率24%,预测效能与12条目原版相似。
- FTS5在衰弱前期人群中可区分65%近基线风险与35%高风险者。
- FTS3(0-30分) cutoff >15,假阴性率31%,预测效能劣于FTS5。
核心结论
- FTS5是易于施测的简版衰弱量表,预测效能与FTS原版相似,可用于临床衰弱诊断与随访。
研究设计与样本
- 前瞻性人群队列研究,数据来自Toledo健康老龄化研究1634名参与者。
主要发现
- FTS5和FTS3对健康不良事件的AUC与12条目FTS相似。
- FTS5 cutoff >25时衰弱患病率24%,FTS3 cutoff >15时患病率20%,而Fried表型衰弱8%、衰弱前期41%。
- FTS5总体预测效能优于Fried表型,尤其衰弱前期中65%近基线风险、35%死亡OR 4、衰弱OR 6.6-8.7、住院OR 1.9-2.1、残疾OR 1.7。
- FTS3在Fried表型判定的衰弱者中假阴性率31%,且不良事件风险高。
关键数值与推荐
- FTS5评分范围0-50,cutoff >25判定衰弱。
- FTS3评分范围0-30,cutoff >15判定衰弱。
- FTS5在衰弱前期中识别35%高风险者:死亡OR 4、衰弱OR 6.6-8.7、住院OR 1.9-2.1、残疾OR 1.7。
临床怎么用
- 临床可使用FTS5(cutoff >25)进行衰弱筛查与风险分层,尤其关注衰弱前期中FTS5判定的高风险个体。
- FTS3因假阴性率较高,不推荐作为首选衰弱评估工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop short versions of the Frailty Trait Scale (FTS) for use in clinical settings. DESIGN: Prospective population-based cohort study. SETTING AND PARTICIPANTS: Data from 1634 participants from the Toledo Study for Healthy Aging. METHODS: The 12-item Frailty Trait Scale (FTS) reduction was performed based on an area under the curve (AUC) analysis adjusted by age, sex, and comorbidity. Items that maximized prognostic information for adverse events were selected. Each item score was done at the same time as the reduction, identifying the score that maximized the predictive ability for adverse events. For each short version of the FTS, cutoffs that optimized the prognostic information (sensitivity and specificity) were chosen, and their predictive value was later compared with a surrogate gold standard for frailty (the Fried Phenotype). RESULTS: Two short forms, the 5-item (FTS5) (range 0-50) and 3-item (FTS3) (range 0-30), were identified, both with AUCs for health adverse events similar to the 12-item FTS. The identified cutoffs were >25 for the FTS5 scale and >15 for the FTS3. The frailty prevalence with these cutoffs was 24% and 20% for the FTS5 and FTS3, respectively, whereas frailty according to Fried Phenotype (FP) reached 8% and prefrailty reached 41%. In general, the FTS5 showed better prognostic performance than the FP, especially with prefrail individuals, in whom the FTS5 form identified 65% of participants with an almost basal risk and 35% with a very high risk for mortality (OR: 4) and frailty (OR: 6.6-8.7), a high risk for hospitalization (OR: 1.9-2.1), and a moderate risk for disability (OR: 1.7) who could be considered frail. The FTS3 form had worse performance than the FTS5, showing 31% of false negatives between frail participants identified by FP with a high risk of adverse events. CONCLUSIONS AND IMPLICATIONS: The FTS5 is a short scale that is easy to administer and has a similar performance to the FTS, and it can be used in clinical settings for frailty diagnosis and evolution.
引用
- García-García FJ, Carnicero JA, Losa-Reyna J, et al. Frailty Trait Scale-Short Form: A Frailty Instrument for Clinical Practice. J Am Med Dir Assoc. 2020. PMID: 32005416. doi:10.1016/j.jamda.2019.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。